Paying users zone. Data is hidden behind: .
Get 1-month access to Illumina Inc. for $13.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Illumina Inc. pages available today for free:
Price to Operating Profit (P/OP)
since 2005
Beginner level
Calculation
Illumina Inc., P/OP, long-term trends, calculation
| P/OP | = | Share price1, 2, 3 | ÷ | Operating profit per share1 | Operating profit per share1 | = | Income (loss) from operations1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2019 | = | ÷ | = | ÷ | |||||||
| Dec 30, 2018 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2017 | = | ÷ | = | ÷ | |||||||
| Jan 1, 2017 | = | ÷ | = | ÷ | |||||||
| Jan 3, 2016 | = | ÷ | = | ÷ | |||||||
| Dec 28, 2014 | = | ÷ | = | ÷ | |||||||
| Dec 29, 2013 | = | ÷ | = | ÷ | |||||||
| Dec 30, 2012 | = | ÷ | = | ÷ | |||||||
| Jan 1, 2012 | = | ÷ | = | ÷ | |||||||
| Jan 2, 2011 | = | ÷ | = | ÷ | |||||||
| Jan 3, 2010 | = | ÷ | = | ÷ | |||||||
| Dec 28, 2008 | = | ÷ | = | ÷ | |||||||
| Dec 30, 2007 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2006 | = | ÷ | = | ÷ | |||||||
| Jan 1, 2006 | = | ÷ | = | ÷ |
Based on: 10-K (filing date: 2020-02-11), 10-K (filing date: 2019-02-12), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-14), 10-K (filing date: 2016-03-02), 10-K (filing date: 2015-02-18), 10-K (filing date: 2014-02-18), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-24), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-02-26), 10-K (filing date: 2009-02-26), 10-K (filing date: 2008-02-26), 10-K (filing date: 2007-02-28), 10-K (filing date: 2006-03-06).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Illumina Inc.’s Annual Report.
Comparison to Competitors
Illumina Inc., P/OP, long-term trends, comparison to competitors
| Illumina Inc. | Abbott Laboratories | AbbVie Inc. | Amgen Inc. | Biogen Inc. | Gilead Sciences Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|
| Dec 29, 2019 | ||||||||
| Dec 30, 2018 | ||||||||
| Dec 31, 2017 | ||||||||
| Jan 1, 2017 | ||||||||
| Jan 3, 2016 | ||||||||
| Dec 28, 2014 | ||||||||
| Dec 29, 2013 | ||||||||
| Dec 30, 2012 | ||||||||
| Jan 1, 2012 | ||||||||
| Jan 2, 2011 | ||||||||
| Jan 3, 2010 | ||||||||
| Dec 28, 2008 | ||||||||
| Dec 30, 2007 | ||||||||
| Dec 31, 2006 | ||||||||
| Jan 1, 2006 |
Based on: 10-K (filing date: 2020-02-11), 10-K (filing date: 2019-02-12), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-14), 10-K (filing date: 2016-03-02), 10-K (filing date: 2015-02-18), 10-K (filing date: 2014-02-18), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-24), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-02-26), 10-K (filing date: 2009-02-26), 10-K (filing date: 2008-02-26), 10-K (filing date: 2007-02-28), 10-K (filing date: 2006-03-06).